Atopic dermatitis treatment: a gastroenterologist’s perspective

Atopic dermatitis (AD) and food allergy (FA) have a significant impact on the health and quality of life of patients. These conditions represent important healthcare problems worldwide. The prevalence of AD among children reaches 20%, which requires early treatment. AD is associated with atopy in 80% of cases and often precedes the development of allergic rhinitis and asthma. Human skin and the gastrointestinal tract (GIT) share a common origin and are linked through the GIT-skin-brain axis. The composition of the GIT microbiota, which depends on both internal conditions and external environmental factors, can be a significant factor in the development of many diseases (atherosclerosis, ischemic heart disease, asthma, AD, etc.). Moisturizers and topical corticosteroids are used as first-line treatment agents for AD. We present our own clinical observations of the shared care of patients by a dermatologist and a gastroenterologist using methylprednisolone aceponate with ceramides and probiotics.